allergy to dexamethasone, peptic ulcer Intraosseous infusion, Dexamethasone, Mandibular third molar
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient is healthy, no systemic disease and allergy, no history of pregnancy and feeding 2.Patient presents mandibular third molar with mesioangular or horizontal bony impaction 3. Bilateral mandibular third molars are asymptomatic and present no pathology 4. Patient can be followed up 5. Patient consent to be participated
Exclusion criteria
Exclusion criteria: 1. Patient with history of anti inflammatory drug within 2 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Swelling postoperative day 3 and 7 (1) distance from corner of mouth to tragus (2) distance from lateral canthus to angle mandible,Mouth opening postoperative day 3 and 7 interincisal distance,Pain immediate after surgery, postoperative day 1,2,3 modified visual analog scale,Pain immediate after surgery, postoperative day 1,2,3,4,5,6,7 number of pain killer intake | — |
Secondary
| Measure | Time frame |
|---|---|
| n/a n/a n/a | — |
Countries
Thailand
Contacts
Faculty of Dentistry, Chiang Mai University